How to Conduct a Medical Device Cybersecurity Risk Assessment (FDA & ISO‑Aligned)

FDA Guidance on Cybersecurity in Medical Devices

FDA expects a risk-based, safety-first approach that embeds security into device design, verification, labeling, and postmarket activities. Your medical device cybersecurity risk assessment should clearly connect threats to patient safety and essential performance, with evidence that controls are effective and maintainable over time.

Align your evidence to Premarket Submission Requirements

• Provide a Security Risk Management Plan and a complete, traceable Security Risk Management File.
• Include threat modeling outputs (assets, data flows, trust boundaries) and attack surface analysis.
• Demonstrate Cybersecurity Risk Controls mapped to risks, with verification and validation results.
• Submit an SBOM and update strategy that covers third‑party components and patch availability.
• Describe Threat Detection Capabilities such as secure logging, alerts, and anomaly monitoring.
• Detail vulnerability handling, coordinated disclosure, and a remediation timeline policy.
• Provide security‑relevant labeling and user instructions that enable safe configuration and maintenance.

Design in patient safety from the start

Use layered security to prevent, detect, and contain harm. Typical Risk Mitigation Strategies include strong authentication and access control, least privilege, secure boot and code signing, encryption at rest and in transit, hardened services, segmentation, secure update and rollback, rate limiting, and resilience features that preserve essential performance under attack.

Verification, validation, and assurance

• Substantiate claims with test evidence: static/dynamic analysis, fuzzing, penetration testing, fault injection, and hardening checklists.
• Show repeatable processes, objective acceptance criteria, and coverage of worst‑case scenarios.
• Summarize claims, arguments, and evidence in a concise assurance case that ties security to safety.

Labeling and deployment readiness

Provide secure configuration guidance, supported protocols/ciphers, password policies, update procedures, and a clear support horizon. Explain how users receive patches, what telemetry is collected, and how Threat Detection Capabilities are enabled without compromising privacy or performance.

ISO 14971 Risk Management Framework

ISO 14971 offers the backbone for risk processes; you apply the same structure to cybersecurity by treating security events as hazard situations that could lead to harm. This ensures decisions are consistent, auditable, and aligned with clinical risk acceptance.

Apply the process to cybersecurity

• Risk analysis: define intended use, interfaces, assets, and potential cybersecurity‑driven hazards.
• Risk estimation: evaluate severity and realistic exploit pathways to patient harm or service disruption.
• Risk evaluation: compare against acceptance criteria and document rationale.
• Risk control: select and implement Cybersecurity Risk Controls; verify effectiveness.
• Residual risk: justify acceptability and communicate any information for safety in labeling.
• Review and report: compile a risk management report and plan for monitoring and feedback.

Estimating cybersecurity risk in practice

Anchor severity in potential clinical outcomes (e.g., delayed therapy, misdiagnosis). Because exploit probability can be uncertain, use scenario‑based reasoning: prerequisite access, required skills, compensating controls, and detectability. Update estimates as new vulnerabilities and threat intelligence emerge.

Risk Mitigation Strategies tied to hazards

• Eliminate or reduce attack surface by design (remove unused ports, harden defaults).
• Break exploit chains through authentication, authorization, and secure communications.
• Limit impact via partitioning, rate limits, and failsafe behaviors that preserve essential performance.
• Detect and respond with logging, alerts, and safe recovery procedures.
• Inform users with clear configuration and maintenance guidance when residual risk remains.

Security Risk Management Documentation

Your documentation proves control of the process, not just the product. Keep it concise, traceable, and living—updated as designs, threats, and environments change.

Security Risk Management Plan

• Scope, roles, interfaces to safety risk management, and methods for analysis and verification.
• Risk acceptance criteria tied to clinical context and essential performance.
• Criteria for vulnerability triage, patch timelines, and communication triggers.

Security Risk Management File

• Asset inventory, architecture, data flow diagrams, and trust boundaries.
• Threat model, hazard analysis, and traceability from risks to Cybersecurity Risk Controls and tests.
• SBOM with component criticality, known vulnerabilities, and patch strategy.
• Verification/validation protocols and results, residual risk justifications, and management reviews.

Regulatory alignment and audits

Organize evidence so it maps directly to FDA expectations and internal Quality Management System Regulation processes. Maintain version control, approvals, and training records so auditors can follow decisions from requirement to release.

Threat Modeling and Vulnerability Assessment

Threat modeling shows where harm could originate and which controls matter most. Vulnerability assessment validates assumptions and finds weaknesses before attackers do.

Performing an effective threat model

• Define assets: patient data, firmware integrity, therapy algorithms, availability.
• Draw data flows and trust boundaries across device, app, cloud, and hospital networks.
• Enumerate threats and misuse cases; prioritize by potential clinical impact.
• Map Risk Mitigation Strategies to each high‑risk path and specify testable requirements.

Vulnerability assessment and testing

• Scan third‑party components from the SBOM; assess findings using exploitability and severity.
• Conduct static/dynamic analysis, fuzz key parsers and protocols, and harden configurations.
• Execute penetration tests representative of real deployments; verify fixes and regressions.
• Exercise Threat Detection Capabilities to prove alerts are timely, accurate, and actionable.

Triaging findings to decisions

Translate technical issues into clinical risk. If a finding can plausibly affect essential performance, escalate priority, implement layered controls, and document the benefit‑risk decision, including any residual risk communication in labeling.

Postmarket Cybersecurity Management

Security does not end at clearance or conformity. Build a closed loop that detects, assesses, remediates, and learns from field signals as part of Postmarket Surveillance.

Monitoring and intake

• Operate a PSIRT with clear intake channels for researchers, customers, and internal teams.
• Use telemetry, logs, and threat intelligence to identify anomalies and emerging issues.
• Continuously evaluate SBOM components for newly disclosed vulnerabilities.

Triage, remediation, and communication

• Assess patient risk promptly; define temporary mitigations and durable fixes.
• Release patches or configuration changes and verify effectiveness in representative environments.
• Communicate impact, mitigations, and timelines to customers and regulators as appropriate.

Governance and metrics

Embed corrective and preventive actions into your QMS, track time‑to‑remediate, vulnerability backlog, and deployment coverage. Update risk files and labeling so Device Lifecycle Risk Management stays current and auditable.

Integration of Cybersecurity in Quality Management Systems

Integrate security into your QMS so controls are systematic, repeatable, and compliant with Quality Management System Regulation. Treat cybersecurity as part of design quality, not an afterthought.

Design controls and change management

• Capture security requirements as design inputs; verify and validate as design outputs.
• Enforce secure coding, peer reviews, and segregation of duties throughout development.
• Run security impact assessments for changes, including field updates and configuration shifts.

Supplier and production controls

• Flow down security requirements, SBOM deliverables, and patch SLAs to suppliers.
• Perform incoming inspections for security‑relevant attributes (e.g., signed firmware).
• Protect manufacturing tools and keys; prevent tampering and unauthorized firmware loading.

Training, audits, and management review

Train staff on secure development and incident response. Include cybersecurity in internal audits and management reviews, ensuring resources and priorities align with patient safety goals.

Ongoing Risk Management Throughout Device Lifecycle

Device Lifecycle Risk Management connects concept, development, manufacturing, deployment, maintenance, and decommissioning. Keep your risk picture current as environments, users, and threats evolve.

Operations and maintenance

• Publish an update policy, including timelines for security patches and supported versions.
• Manage cryptographic keys and certificates; rotate and revoke when needed.
• Continuously tune Threat Detection Capabilities using field data and lessons learned.

End‑of‑life planning

• Announce end‑of‑support dates, provide migration guidance, and offer safe configurations.
• Sanitize or securely decommission data and credentials to prevent residual exposure.
• Document final residual risks and communicate any limitations clearly to users.

Conclusion

A rigorous medical device cybersecurity risk assessment links threats to patient safety, implements layered controls, and proves effectiveness with evidence. By aligning with FDA guidance, applying ISO 14971 discipline, integrating processes into your QMS, and sustaining Postmarket Surveillance, you create durable protection across the entire lifecycle.

FAQs.

What is the role of FDA guidance in medical device cybersecurity risk assessments?

FDA guidance sets expectations for how you demonstrate that cybersecurity risks are identified, controlled, and monitored. It shapes Premarket Submission Requirements, defines the evidence you provide (e.g., threat models, SBOM, test results), and explains postmarket practices like coordinated disclosure and patching to protect patient safety.

How does ISO 14971 apply to cybersecurity risk management?

ISO 14971 supplies the structure for analyzing hazards, estimating and evaluating risk, implementing controls, and justifying residual risk. You apply it to cybersecurity by treating security events as hazard situations, mapping Cybersecurity Risk Controls to those hazards, and maintaining a traceable, living file throughout the lifecycle.

What documentation is required for security risk management in medical devices?

You need a Security Risk Management Plan, a comprehensive Security Risk Management File with traceability, threat modeling artifacts, SBOM, verification and validation results, residual risk justifications, labeling content, and procedures for vulnerability handling. These records should align with Quality Management System Regulation processes and be ready for regulatory review.

How should manufacturers manage cybersecurity risks postmarket?

Establish a PSIRT, monitor field signals as part of Postmarket Surveillance, triage findings based on patient risk, and deploy timely mitigations and patches. Communicate clearly with customers and regulators, update the Security Risk Management File and labeling, and feed lessons learned into continuous improvement and Device Lifecycle Risk Management.